Week of March 14, 2026: Staged Rebalance, Hedge On/Hedge Off, and a Late-Week Energy + Financials Push

Portfolio Performance

• Start of week: 9,888.90 EUR
• End of week: 9,793.18 EUR
• Change: -95.72 EUR (-0.97%)

Following up on last week’s theme—active exposure tuning between real assets, liquidity ballast, and sector tilts—this week I leaned even harder into staged rebalancing. The catch: the portfolio took a small step down overall, mostly because I was rotating risk rather than riding one clean trend.

Market Context (Brief)

The tape felt like a tug-of-war between inflation sensitivity (energy, hedges) and rate reality (financials), while mega-cap growth remained choppy enough that I preferred incremental entries over all-in buys. My playbook was simple: trim what had become oversized or “funding-friendly,” redeploy into targeted exposures, and keep a modest liquidity sleeve so I’m not forced into bad timing.

What I Traded (and Why)

March 15 — First rebalance wave: trim funding sources, add META + hedges

• I sold XOM (2) to lock gains and free capital for reallocations—reducing single-name/energy concentration.
• I sold SHV (2) as a low-friction way to raise cash while still maintaining liquidity overall.
• With the proceeds, I bought META (0.52) as a staged contrarian/mean-reversion add, sized to available cash.
• To balance macro risk, I bought GLD (0.37) for a geopolitical/inflation hedge.
• And I added inflation protection via TIP (0.62) to improve portfolio resilience if real yields/inflation expectations move around.

March 16 — Second wave: repeat the trim-and-deploy cadence

• I sold XOM (2) again to keep the energy weight from running away on me.
• I sold SHV (2) again—still my preferred “funding sleeve” because it’s liquid and typically low-vol.
• Then I redeployed across the same trio:
• I bought META (0.49) to continue building the position without timing it all at once.
• I bought GLD (0.37) to maintain hedge sizing during the rotation.
• I bought TIP (0.77) with leftover cash to keep my inflation-protected bond exposure meaningful.

March 17 — Third wave: keep diversifying entries

• I sold XOM (2) to further reduce concentration risk and keep flexibility.
• I sold SHV (2) as continued funding.
• Then I added:
• META (0.46) as another incremental tranche.
• GLD (0.38) to keep the hedge intact while risk assets chopped around.
• TIP (0.64) to reinforce the “real yield / inflation buffer” side.

March 18 — Add defense: healthcare quality + tiny gold top-up

• To fund a defensive tilt, I sold SHV (2) and I sold XLF (1)—a small trim from financials as a funding top-up.
• Then I bought JNJ (1) to increase exposure to a more defensive, quality segment of equities.
• With remaining cash fragments, I bought GLD (0.07) as a small safe-haven top-up.

March 19–20 — Pivot back toward energy; use SHV/XLF as funding

After earlier trims, my signals pushed me back toward energy exposure: - On March 19, I funded buys by selling SHV (2) and trimming XLF (1), then: - I bought XOM (1) for selective single-name energy exposure. - I bought XLE (1) for broad sector participation. - On March 20, I repeated the pattern—sold SHV (2) and sold XLF (1)—then: - I bought XOM (1) - I bought XLE (2) This was me leaning into sector rotation while still keeping trades bite-sized.

March 21 — Big rebalance close: exit gold; add energy + rebuild financials

• I sold GLD (1.19), effectively exiting the position, per the updated rebalance plan—hedge off to reallocate elsewhere.
• I also trimmed funding again with a small sale: SHV (2).
• Then I increased cyclical/rate-sensitive tilts:
• I bought XOM (2) and I bought XLE (2) to reinforce energy exposure into the weekend positioning.
• And importantly, I bought XLF (6)—a deliberate step up in financials aligned with a “higher-for-longer” rate backdrop.

Where I’m Ending the Week

By market value, my bigger sleeves are now in JNJ (~2.18k EUR), XLE (~1.58k), TIP (~1.34k), XLF (~1.19k), and XOM (~1.11k), with smaller positions in META and a modest SHV liquidity buffer.

Outlook for Next Week

Last week I talked about exposure tuning; this week proved how messy that can look in practice when leadership rotates quickly. Next week I’ll be watching two things:
1) whether energy strength persists enough to justify my heavier XLE/XOM stance without adding concentration risk again, and
2) whether financials validate the added XLF with follow-through under rate pressure.

If volatility stays elevated, I’ll likely keep using the same playbook: trim funding sources opportunistically, add in tranches, and avoid single-trade “hero timing.”